ChoA Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
ChoA Pharmaceutical has a total shareholder equity of ₩35.5B and total debt of ₩22.8B, which brings its debt-to-equity ratio to 64.3%. Its total assets and total liabilities are ₩76.0B and ₩40.5B respectively.
Key information
64.3%
Debt to equity ratio
₩22.82b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩8.22b |
| Equity | ₩35.52b |
| Total liabilities | ₩40.53b |
| Total assets | ₩76.05b |
Financial Position Analysis
Short Term Liabilities: A034940's short term assets (₩44.4B) exceed its short term liabilities (₩32.7B).
Long Term Liabilities: A034940's short term assets (₩44.4B) exceed its long term liabilities (₩7.8B).
Debt to Equity History and Analysis
Debt Level: A034940's net debt to equity ratio (41.1%) is considered high.
Reducing Debt: A034940's debt to equity ratio has increased from 31.6% to 64.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A034940 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A034940 has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 40.1% each year.